These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21199224)

  • 41. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis.
    de Rooij A; Vandenbroucke JP; Smit JW; Stokkel MP; Dekkers OM
    Eur J Endocrinol; 2009 Nov; 161(5):771-7. PubMed ID: 19671708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subclinical hyperthyroidism in the course of autonomous nodules - clinical evaluation.
    Rudzki GM; Lenart-Lipińska M; Smoleń A; Chrapko BE; Matyjaszek-Matuszek B
    Endokrynol Pol; 2019; 70(2):157-164. PubMed ID: 30480751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
    van Isselt JW; de Klerk JM; Lips CJ
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1883-4. PubMed ID: 17874093
    [No Abstract]   [Full Text] [Related]  

  • 44. Short-term results of Na131I treatment of hyperthyroidism evaluated using an extended dosimetric method.
    Camps MJ; van Geel JL; Haak HR; Ribot JG; Blonk MC; Bravenboer B
    Neth J Med; 1996 Oct; 49(4):143-9. PubMed ID: 8937082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
    Sisson JC; Avram AM; Rubello D; Gross MD
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1129-30. PubMed ID: 17457585
    [No Abstract]   [Full Text] [Related]  

  • 46. Lithium carbonate as add-on therapy to radioiodine in the treatment on hyperthyroidism: a systematic review and meta-analysis.
    Abd-ElGawad M; Abdelmonem M; Ahmed AE; Mohammed OM; Zaazouee MS; Assar A; Gadelkarim M; Afifi AM
    BMC Endocr Disord; 2021 Apr; 21(1):64. PubMed ID: 33840391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of the External Dose Rate and Retained Body Activity of Patients with Hyperthyroidism Who Are Receiving I-131 Therapy.
    Liu YL; Zhao ZX; Huo MH; Yin C; Tan J; Zhang WY; Jiao L
    Biomed Environ Sci; 2018 Dec; 31(12):913-916. PubMed ID: 30636664
    [No Abstract]   [Full Text] [Related]  

  • 48. Internet fraud targeting authors of this journal.
    Gupta SK; Rogers K
    Intern Med J; 2011 Jul; 41(7):582. PubMed ID: 21762343
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparison of radioiodine test in the diagnosis of hyperthyroidism.
    GOOLDEN AW
    Br J Radiol; 1958 Aug; 31(368):433-6. PubMed ID: 13560750
    [No Abstract]   [Full Text] [Related]  

  • 50. Dose rate measurements combined with social behavior models enables estimation of potential radiation hazards to families of patients treated with radioiodine.
    Barrington SF; O'Doherty MJ; Kettle AG; Mountford PJ
    Health Phys; 2000 Jan; 78(1):100-1. PubMed ID: 10608318
    [No Abstract]   [Full Text] [Related]  

  • 51. Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism.
    Nilsson JN; Elovsson R; Thor D; Calissendorff J; Ardenfors O
    Thyroid Res; 2022 Apr; 15(1):8. PubMed ID: 35462539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting outcomes in hyperthyroid cats treated with radioiodine.
    Peterson ME; Rishniw M
    J Vet Intern Med; 2022 Jan; 36(1):49-58. PubMed ID: 34817910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm.
    Schiavo M; Bagnara MC; Camerieri L; Pomposelli E; Giusti M; Pesce G; Reitano C; Caputo M; Bagnasco M
    Endocrine; 2015 Apr; 48(3):902-8. PubMed ID: 25151403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors.
    Gupta SK; McGrath S; Rogers K; Attia J; Lewis G; Viswanathan S; Saul M; Allen L
    Intern Med J; 2010 Dec; 40(12):854-7. PubMed ID: 21199224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.